Stan Krulewicz

1.1k total citations
27 papers, 666 citations indexed

About

Stan Krulewicz is a scholar working on Pulmonary and Respiratory Medicine, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, Stan Krulewicz has authored 27 papers receiving a total of 666 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 9 papers in Psychiatry and Mental health and 6 papers in Pharmacology. Recurrent topics in Stan Krulewicz's work include Renal cell carcinoma treatment (7 papers), Economic and Financial Impacts of Cancer (4 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (3 papers). Stan Krulewicz is often cited by papers focused on Renal cell carcinoma treatment (7 papers), Economic and Financial Impacts of Cancer (4 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (3 papers). Stan Krulewicz collaborates with scholars based in United States, United Kingdom and Germany. Stan Krulewicz's co-authors include David Carpenter, Prakash S. Masand, Kathleen Peindl, Ashwin A. Patkar, Paolo Mannelli, David V. Sheehan, Jonathan Davidson, Michael J. Owens, Alan Lipschitz and Charles B. Nemeroff and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and The American Journal of Medicine.

In The Last Decade

Stan Krulewicz

26 papers receiving 634 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Stan Krulewicz 235 216 210 78 78 27 666
Christina Rosenberger 117 0.5× 178 0.8× 49 0.2× 61 0.8× 42 0.5× 23 863
Marc Udina 197 0.8× 90 0.4× 65 0.3× 14 0.2× 61 0.8× 17 659
Whitney N. Rebholz 98 0.4× 141 0.7× 46 0.2× 141 1.8× 86 1.1× 11 536
L. Pauer 405 1.7× 60 0.3× 402 1.9× 54 0.7× 83 1.1× 39 1.1k
Eileen B. Brown 311 1.3× 265 1.2× 302 1.4× 14 0.2× 110 1.4× 17 866
Muhammad Abid Azam 32 0.1× 121 0.6× 105 0.5× 80 1.0× 62 0.8× 31 641
G. R. McClelland 123 0.5× 45 0.2× 121 0.6× 16 0.2× 61 0.8× 20 495
Keith Karcher 1.2k 5.2× 264 1.2× 214 1.0× 8 0.1× 33 0.4× 27 1.5k
Evanthia C. Wommack 155 0.7× 50 0.2× 85 0.4× 108 1.4× 80 1.0× 22 885
Pilar Sierra 494 2.1× 130 0.6× 115 0.5× 8 0.1× 145 1.9× 56 783

Countries citing papers authored by Stan Krulewicz

Since Specialization
Citations

This map shows the geographic impact of Stan Krulewicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stan Krulewicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stan Krulewicz more than expected).

Fields of papers citing papers by Stan Krulewicz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stan Krulewicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stan Krulewicz. The network helps show where Stan Krulewicz may publish in the future.

Co-authorship network of co-authors of Stan Krulewicz

This figure shows the co-authorship network connecting the top 25 collaborators of Stan Krulewicz. A scholar is included among the top collaborators of Stan Krulewicz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stan Krulewicz. Stan Krulewicz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bauman, Jessica R., Geoffrey Liu, Isabel R. Preeshagul, et al.. (2024). Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK-positive advanced non-small cell lung cancer. Lung Cancer. 195. 107919–107919. 2 indexed citations
2.
Dagogo‐Jack, Ibiayi, Antonello Abbattista, Stan Krulewicz, et al.. (2022). Factors Associated With Developing Neurocognitive Adverse Events in Patients Receiving Lorlatinib After Progression on Other Targeted Therapies. Journal of Thoracic Oncology. 18(1). 67–78. 21 indexed citations
3.
4.
5.
Waterhouse, David, Laura Iadeluca, Keith D. Wilner, et al.. (2021). Real-World Outcomes Among Crizotinib-Treated Patients with ROS1-Positive Advanced Non-Small-Cell Lung Cancer: A Community Oncology-Based Observational Study. Targeted Oncology. 17(1). 25–33. 10 indexed citations
6.
Zheng, Ying, et al.. (2019). Exploratory analysis of the cost of episodes of care in metastatic renal cell carcinoma in the United States.. Journal of Clinical Oncology. 37(27_suppl). 55–55.
7.
Masand, Prakash S., Chi‐Un Pae, Stan Krulewicz, et al.. (2009). A Double-Blind, Randomized, Placebo-Controlled Trial of Paroxetine Controlled-Release in Irritable Bowel Syndrome. Psychosomatics. 50(1). 78–86. 59 indexed citations
8.
Pae, Chi‐Un, Prakash S. Masand, David M. Marks, et al.. (2009). History of early abuse as a predictor of treatment response in patients with fibromyalgia: A post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release. The World Journal of Biological Psychiatry. 10(4-2). 435–441. 11 indexed citations
9.
Owens, Michael J., Stan Krulewicz, Jeffrey S. Simon, et al.. (2008). Estimates of Serotonin and Norepinephrine Transporter Inhibition in Depressed Patients Treated with Paroxetine or Venlafaxine. Neuropsychopharmacology. 33(13). 3201–3212. 49 indexed citations
10.
Sheehan, David V., et al.. (2008). Differences in Medication Adherence and Healthcare Resource Utilization Patterns. CNS Drugs. 22(11). 963–973. 70 indexed citations
11.
Masand, Prakash S., Stan Krulewicz, Kathleen Peindl, et al.. (2008). Childhood abuse and treatment response in patients with irritable bowel syndrome: apost-hocanalysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release. Journal of Clinical Pharmacy and Therapeutics. 34(1). 79–88. 12 indexed citations
12.
Simon, Naomi M., Kathryn M. Connor, Ariel J. Lang, et al.. (2008). Paroxetine CR Augmentation for Posttraumatic Stress Disorder Refractory to Prolonged Exposure Therapy. The Journal of Clinical Psychiatry. 69(3). 400–405. 67 indexed citations
13.
Marks, David M., Stan Krulewicz, Chi-Un Pae, et al.. (2008). History of Depressive and Anxiety Disorders and Paroxetine Response in Patients With Irritable Bowel Syndrome. The Primary Care Companion to The Journal of Clinical Psychiatry. 10(5). 368–375. 8 indexed citations
14.
Patkar, Ashwin A., Prakash S. Masand, Stan Krulewicz, et al.. (2007). A Randomized, Controlled, Trial of Controlled Release Paroxetine in Fibromyalgia. The American Journal of Medicine. 120(5). 448–454. 72 indexed citations
15.
Wasser, Thomas, et al.. (2006). Effects of Paroxetine CR on Depressive and Anxiety Symptoms: In a Community Sample of Adult Hispanic Women with Major Depression or Generalized Anxiety Disorder.. PubMed Central. 4 indexed citations
16.
Apter, Alan, Alan Lipschitz, Regan Fong, et al.. (2006). Evaluation of Suicidal Thoughts and Behaviors in Children and Adolescents Taking Paroxetine. Journal of Child and Adolescent Psychopharmacology. 16(1-2). 77–90. 21 indexed citations
17.
Krulewicz, Stan, David Carpenter, Regan Fong, et al.. (2006). Analysis of Electrocardiographic Data Following Use of Paroxetine in Pediatric Depression and Obsessive-Compulsive Disorder. Journal of the American Academy of Child & Adolescent Psychiatry. 45(4). 422–430. 5 indexed citations
18.
Emslie, Graham J., Karen Dineen Wagner, Stan Kutcher, et al.. (2006). Paroxetine Treatment in Children and Adolescents With Major Depressive Disorder: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial. Journal of the American Academy of Child & Adolescent Psychiatry. 45(6). 709–719. 105 indexed citations
19.
Davidson, Jonathan, Lana L. Watkins, Michael J. Owens, et al.. (2005). Effects of Paroxetine and Venlafaxine XR on Heart Rate Variability in Depression. Journal of Clinical Psychopharmacology. 25(5). 480–484. 68 indexed citations
20.
Watkins, Lana L., Jonathan Davidson, Kathryn M. Connor, et al.. (2003). P.1.233 Effects of paroxetine and venlafaxine-XP on heart rate variability in depression. European Neuropsychopharmacology. 13. S274–S274. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christina Rosenberger Breakdown of academic impact, for papers by Marc Udina Breakdown of academic impact, for papers by Whitney N. Rebholz Breakdown of academic impact, for papers by L. Pauer Breakdown of academic impact, for papers by Eileen B. Brown Breakdown of academic impact, for papers by Muhammad Abid Azam Breakdown of academic impact, for papers by G. R. McClelland Breakdown of academic impact, for papers by Keith Karcher Breakdown of academic impact, for papers by Evanthia C. Wommack Breakdown of academic impact, for papers by Pilar Sierra
Rankless by CCL
2026